Repatha Case Study

Objective :

  • Launching Amgen’s new drug “Evolocumab” in Egypt that treats high cholesterol for cardiovascular diseases
  • Educate the public on the drug’s benefits and usage


  • Mark an exciting milestone for Amgen in their ongoing commitment to cardiovascular disease
    • A Press Conference to launch Amgen’s new medicine “Evolocumab”
    • Presence of Media and TVs to cover the event


  • 105 Coverage with 825,009,788 Media Impressions
  • 3 TV Interviews on major Egyptian TV Channels